MedTrace Logo

Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer

NCT06477003 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-01-28

No results posted yet for this study

Summary

The purpose of this research is to assess the safety and evaluate the potential of the Multispectral Optoacoustic Tomography (MSOT) device to more precisely identify and assess the neck lymph nodes which might be affected in patients with metastatic head and neck squamous cell carcinomas.

Conditions

Interventions

DEVICE

Multispectral Optoacoustic Tomography

The MSOT device will be used to take images of the tumor or affected lymph nodes of patients with head and neck squamous cell carcinoma.

PROCEDURE

Temperature Measurement

The temperature of the skin will be measured prior to and after MSOT imaging.

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Christina Henson, MD · University of Oklahoma

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2026-11-30
Completion
2027-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06477003 on ClinicalTrials.gov